Novel 5′ fusion partners of ETV1 and ETV4 in prostate cancer

Neoplasia (United States)

Volumn 15, Issue 7, 2013, Pages 720-726

  Barros Silva, João D ^a,b,c   Paulo, Paula ^a,b,c   Bakken, Anne Cathrine ^b,c   Cerveira, Nuno ^a   Løvf, Marthe ^b,c   Henrique, Rui ^a,d   Jerónimo, Carmen ^a,d   Lothe, Ragnhild A ^b,c   Skotheim, Rolf Inge ^b,c   Teixeira, Manuel R ^a,c,d  

^a PORTUGUESE ONCOLOGY INSTITUTE   (Portugal)

^b OSLO UNIVERSITY HOSPITAL   (Norway)

^c UNIVERSITY OF OSLO   (Norway)

^d UNIVERSITY OF PORTO   (Portugal)

Author keywords

[No Author keywords available]

Indexed keywords

COMPLEMENTARY DNA; TRANSCRIPTION FACTOR; TRANSCRIPTION FACTOR ER81; TRANSCRIPTION FACTOR ETV4; UNCLASSIFIED DRUG; DNA BINDING PROTEIN; E1A PROTEIN; ETV1 PROTEIN, HUMAN; ETV4 PROTEIN, HUMAN; OLFACTORY RECEPTOR; ONCOPROTEIN; OR51E2 PROTEIN, HUMAN; TRANSCRIPTION FACTOR UBF; TUMOR PROTEIN;

ARTICLE; BACTERIAL ARTIFICIAL CHROMOSOME; COMPUTER MODEL; EXON; FLUORESCENCE IN SITU HYBRIDIZATION; GENE EXPRESSION; GENE FUSION; GENE REARRANGEMENT; GENE SEQUENCE; GENETIC HETEROGENEITY; HUMAN; HUMAN TISSUE; MAJOR CLINICAL STUDY; MICROARRAY ANALYSIS; NUCLEOTIDE SEQUENCE; PRIORITY JOURNAL; PROSTATE CANCER; PROSTATECTOMY; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; SEQUENCE ANALYSIS; CELL TRANSFORMATION; GENE EXPRESSION PROFILING; GENETICS; MALE; OLFACTORY RECEPTOR; PROSTATE TUMOR;

ADENOVIRUS E1A PROTEINS; CELL TRANSFORMATION, NEOPLASTIC; DNA-BINDING PROTEINS; GENE EXPRESSION PROFILING; GENE REARRANGEMENT; HUMANS; MALE; NEOPLASM PROTEINS; ONCOGENE PROTEINS, FUSION; POL1 TRANSCRIPTION INITIATION COMPLEX PROTEINS; PROSTATIC NEOPLASMS; PROTO-ONCOGENE PROTEINS; RECEPTORS, ODORANT; TRANSCRIPTION FACTORS;

EID: 84879632065     PISSN: 15228002     EISSN: 14765586     Source Type: Journal    
DOI: 10.1593/neo.13232     Document Type: Article

References (27)

1. Tomlins SA, Rhodes DR, Perner S, Dhanasekaran SM, Mehra R, Sun XW, Varambally S, Cao X, Tchinda J, Kuefer R, et al. (2005). Recurrent fusion of TMPRSS2 and ETS transcription factor genes in prostate cancer. Science 310, 644-648.
2. Clark JP and Cooper CS (2009). ETS gene fusions in prostate cancer. Nat Rev Urol 6, 429-439.
3. Paulo P, Barros-Silva JD, Ribeiro FR, Ramalho-Carvalho J, Jeronimo C, Henrique R, Lind GE, Skotheim RI, Lothe RA, and Teixeira MR (2012). FLI1 is a novel ETS transcription factor involved in gene fusions in prostate cancer. Genes Chromosomes Cancer 51, 240-249.
4. Cerveira N, Ribeiro FR, Peixoto A, Costa V, Henrique R, Jeronimo C, and Teixeira MR (2006). TMPRSS2-ERG gene fusion causing ERG overexpression precedes chromosome copy number changes in prostate carcinomas and paired HGPIN lesions. Neoplasia 8, 826-832.
5. Tomlins SA, Mehra R, Rhodes DR, Smith LR, Roulston D, Helgeson BE, Cao X, Wei JT, Rubin MA, Shah RB, et al. (2006). TMPRSS2:ETV4 gene fusions define a third molecular subtype of prostate cancer. Cancer Res 66, 3396-3400.
6. Helgeson BE, Tomlins SA, Shah N, Laxman B, Cao Q, Prensner JR, Cao X, Singla N, Montie JE, Varambally S, et al. (2008). Characterization of TMPRSS2:ETV5 and SLC45A3:ETV5 gene fusions in prostate cancer. Cancer Res 68, 73-80.
7. Maher CA, Palanisamy N, Brenner JC, Cao X, Kalyana-Sundaram S, Luo S, Khrebtukova I, Barrette TR, Grasso C, Yu J, et al. (2009). Chimeric transcript discovery by paired-end transcriptome sequencing. Proc Natl Acad Sci USA 106, 12353-12358.
8. Pflueger D, Rickman DS, Sboner A, Perner S, LaFargue CJ, Svensson MA, Moss BJ, Kitabayashi N, Pan Y, de la Taille A, et al. (2009). N-myc downstreamregulated gene 1 (NDRG1) is fused to ERG in prostate cancer. Neoplasia 11, 804-811.
9. Barros-Silva JD, Ribeiro FR, Rodrigues A, Cruz R, Martins AT, Jeronimo C, Henrique R, and Teixeira MR (2011). Relative 8q gain predicts disease-specific survival irrespective of the TMPRSS2-ERG fusion status in diagnostic biopsies of prostate cancer. Genes Chromosomes Cancer 50, 662-671.
10. Rajan P, Dalgliesh C, Carling PJ, Buist T, Zhang C, Grellscheid SN, Armstrong K, Stockley J, Simillion C, Gaughan L, et al. (2011). Identification of novel androgen-regulated pathways and mRNA isoforms through genome-wide exonspecific profiling of the LNCaP transcriptome. PLoS One 6, e29088.
11. Paulo P, Ribeiro FR, Santos J, Mesquita D, Almeida M, Barros-Silva JD, Itkonen H, Henrique R, Jeronimo C, Sveen A, et al. (2012). Molecular subtyping of primary prostate cancer reveals specific and shared target genes of different ETS rearrangements. Neoplasia 14, 600-611.
12. Attard G, Clark J, Ambroisine L, Mills IG, Fisher G, Flohr P, Reid A, Edwards S, Kovacs G, Berney D, et al. (2008). Heterogeneity and clinical significance of ETV1 translocations in human prostate cancer. Br J Cancer 99, 314-320.
13. Hermans KG, van der Korput HA, van Marion R, van de Wijngaart DJ, Ziel-van der Made A, Dits NF, Boormans JL, van der Kwast TH, van Dekken H, Bangma CH, et al. (2008). Truncated ETV1, fused to novel tissue-specific genes, and full-length ETV1 in prostate cancer. Cancer Res 68, 7541-7549.
14. Xu LL, Stackhouse BG, Florence K, Zhang W, Shanmugam N, Sesterhenn IA, Zou Z, Srikantan V, Augustus M, Roschke V, et al. (2000). PSGR, a novel prostate-specific gene with homology to a G protein-coupled receptor, is overexpressed in prostate cancer. Cancer Res 60, 6568-6572.
15. Weng J, Ma W, Mitchell D, Zhang J, and Liu M (2005). Regulation of human prostate-specific G-protein coupled receptor, PSGR, by two distinct promoters and growth factors. J Cell Biochem 96, 1034-1048.
16. Vaarala MH, Hirvikoski P, Kauppila S, and Paavonen TK (2012). Identification of androgen-regulated genes in human prostate. Mol Med Rep 6, 466-472.
17. Han B, Mehra R, Dhanasekaran SM, Yu J, Menon A, Lonigro RJ, Wang X, Gong Y, Wang L, Shankar S, et al. (2008). A fluorescence in situ hybridization screen for E26 transformation-specific aberrations: identification of DDX5-ETV4 fusion protein in prostate cancer. Cancer Res 68, 7629-7637.
18. Jones KA, Black DM, Griffiths BL, and Solomon E (1995). Localization of the human RNA polymerase I transcription factor gene (UBTF) to the D17S183 locus on chromosome 17q21 and construction of a long-range restriction map of the region. Genomics 30, 602-604.
19. Matera AG, Wu W, Imai H, O'Keefe CL, and Chan EK (1997). Molecular cloning of the RNA polymerase I transcription factor hUBF/NOR-90 (UBTF) gene and localization to 17q21.3 by fluorescence in situ hybridization and radiation hybrid mapping. Genomics 41, 135-138.
20. Grandori C, Gomez-Roman N, Felton-Edkins ZA, Ngouenet C, Galloway DA, Eisenman RN, and White RJ (2005). c-Myc binds to human ribosomal DNA and stimulates transcription of rRNA genes by RNA polymerase I. Nat Cell Biol 7, 311-318.
21. Poortinga G, Hannan KM, Snelling H, Walkley CR, Jenkins A, Sharkey K, Wall M, Brandenburger Y, Palatsides M, Pearson RB, et al. (2004). MAD1 and c-MYC regulate UBF and rDNA transcription during granulocyte differentiation. EMBO J 23, 3325-3335.
22. Tomlins SA, Laxman B, Dhanasekaran SM, Helgeson BE, Cao X, Morris DS, Menon A, Jing X, Cao Q, Han B, et al. (2007). Distinct classes of chromosomal rearrangements create oncogenic ETS gene fusions in prostate cancer. Nature 448, 595-599.
23. Gasi D, van der Korput HA, Douben HC, de Klein A, de Ridder CM, van Weerden WM, and Trapman J (2011). Overexpression of full-length ETV1 transcripts in clinical prostate cancer due to gene translocation. PLoS One 6, e16332.
24. Lin C, Yang L, Tanasa B, Hutt K, Ju BG, Ohgi K, Zhang J, Rose DW, Fu XD, Glass CK, et al. (2009). Nuclear receptor-induced chromosomal proximity and DNA breaks underlie specific translocations in cancer. Cell 139, 1069-1083.
25. Haffner MC, Aryee MJ, Toubaji A, Esopi DM, Albadine R, Gurel B, Isaacs WB, Bova GS, Liu W, Xu J, et al. (2010). Androgen-induced TOP2B-mediated double-strand breaks and prostate cancer gene rearrangements. Nat Genet 42, 668-675.
26. Engreitz JM, Agarwala V, and Mirny LA (2012). Three-dimensional gen ome architecture influences partner selection for chromosomal translocations in human disease. PLoS One 7, e44196.
27. Kilpinen S, Autio R, Ojala K, Iljin K, Bucher E, Sara H, Pisto T, Saarela M, Skotheim RI, Björkman M, et al. (2008). Systematic bioinformatic analysis of expression levels of 17,330 human genes across 9,783 samples from 175 types of healthy and pathological tissues. Genome Biol 9, R139.